ASX:GSS Genetic Signatures (GSS) Stock Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Genetic Signatures alerts: Email Address Ad Crypto 101 MediaThe #1 Altcoin for September 2024With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Now, I'm about to reveal the #1 crypto for September 2024. Go here to get full details on this crypto now. About Genetic Signatures Stock (ASX:GSS)Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.Read More Ad Crypto 101 MediaThe #1 Altcoin for September 2024With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Now, I'm about to reveal the #1 crypto for September 2024. Go here to get full details on this crypto now. GSS Stock News HeadlinesSeptember 11 at 1:47 PM | msn.comScientists expand the genetic alphabet to create new proteinsAugust 31, 2024 | finance.yahoo.comGenetic Signatures Full Year 2024 Earnings: EPS Misses ExpectationsSeptember 13, 2024 | Monetary Gold (Ad)Biden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.August 9, 2024 | msn.comBlueprint for blueberry improvement: Genetic and epigenetic discoveriesAugust 9, 2024 | msn.comGenetic signatures provide prognostic information in colorectal cancerAugust 9, 2024 | finance.yahoo.comGenetic Signatures (ASX:GSS) shareholders have endured a 41% loss from investing in the stock three years agoAugust 2, 2024 | msn.comGenetic signatures of domestication identified in pigs and chickensJuly 25, 2024 | msn.comProteomic signatures enhance risk prediction for both common and rare diseasesSeptember 13, 2024 | Monetary Gold (Ad)Biden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.May 25, 2024 | msn.comUCLA research connects genetic risk and brain changes in autismMay 24, 2024 | msn.comStudy connects genetic risk for autism to changes observed in the brainMay 20, 2024 | msn.comGenetic resilience and adaptation of the endangered Chinese hazelnutMay 17, 2024 | msn.comNovel genetic mechanisms may serve as therapeutic target against gliomaMarch 6, 2024 | msn.comGenetic mutation in a quarter of all Labradors hard-wires them for obesityFebruary 6, 2024 | msn.comResearchers at U of C reveal new kit making genetic mutation testing quick, accessible, affordableFebruary 6, 2024 | msn.comResearchers create a new tool to rapidly diagnose genetic mutationsJanuary 13, 2024 | money.usnews.comGenetic Counselor SalaryJanuary 5, 2024 | morningstar.comGenetic Signatures Ltd GSSSee More Headlines Receive GSS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genetic Signatures and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:GSS CUSIPN/A CIKN/A Webwww.geneticsignatures.com Phone61 2 9870 7580FaxN/AEmployees1,626Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,040,000.00 Net Margins-112.83% Pretax MarginN/A Return on Equity-40.28% Return on Assets-23.50% Debt Debt-to-Equity Ratio0.03 Current Ratio8.06 Quick Ratio8.54 Sales & Book Value Annual Sales$15.99 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.28 per share Price / BookN/AMiscellaneous Outstanding Shares226,570,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.05 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesDr. Neil Gunn (Age 63)Interim CEO & Non-Executive Director Comp: $89.21kMr. Michael Anton Aicher BSc (Age 64)M.B.A., MBA, Executive Director of US Operations & Executive Director Comp: $178.42kMr. Christopher M. AbbottFounder & Chairman EmeritusMr. Karl David PechmannCFO, COO & Company SecretaryDr. Douglas S. Millar BScPh.D., Chief Scientific OfficerMs. Rebecca AbbatantuonoGlobal Head of People & CultureMs. Neralie Coulston B.Sc.Global Head of Regulatory AffairsMr. Jackson Jones B.Sc.Chief Commercial OfficerMore ExecutivesKey CompetitorsANGLEOTCMKTS:ANPCYAustralian Clinical LabsASX:ACLBARD1 Life SciencesASX:BD1BCAL DiagnosticsASX:BDXbioAffinity TechnologiesNASDAQ:BIAFWView All CompetitorsInsidersNicholas SamarasSold 46,892 sharesTotal: $35,169.00 ($0.75/share)Stephane ChatonskyBought 112,733 shares on 2/27/2024Total: $58,621.16 ($0.52/share) This page (ASX:GSS) was last updated on 9/13/2024 by MarketBeat.com Staff From Our PartnersInvest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges ...Deal Maker | SponsoredYou won’t believe what this ex-Wall Street insider discovered about the electionOne ex-Wall Street insider recently combed through 64 years of election data… And he just uncovered somethi...Banyan Hill Publishing | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳High-Growth Smartphone Startup 45 Million Users. $60M+ in Revenue. 32,481% Growth Rate. $1T+ market opportu...Mode Mobile | SponsoredBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredPlace this $0.99 trade BEFORE the electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredAmerica dodged a crisis — next time it could be much worseLegendary financial forecaster, Dr. Martin Weiss, has been warning us about it for months … He believes the...Weiss Ratings | SponsoredThe $15 "Insider Secret" That Could Save Your RetirementWhat if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's righ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetic Signatures Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Genetic Signatures With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
